Literature DB >> 32540339

CTRP9: An emerging potential anti-aging molecule in brain.

Aysa Rezabakhsh1, Yalda Sadeghpour2, Shahrouz Ghaderi3, Reza Rahbarghazi4, Mohammad Hossein Geranmayeh5.   

Abstract

C1q/tumor necrosis factor (TNF)-related proteins (CTRPs) particularly CTRP9, have been established to be as adiponectin (APN) highly conserved paralogs which assemble several APN regulatory functions. Recently, growing body of evidences drawn significant attention to evaluate metabolic and cardiovascular effect of CTRP9. However, the potential role of CTRP9 in brain tissue has not yet fully illustrated. Here, we aimed to uncover latest advances regarding the CTRP9 related signaling pathways and during brain aging process.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Adiponectin; Aging; Brain tissue; C1q/tumor necrosis factor (TNF)-related proteins (CTRPs)

Year:  2020        PMID： 32540339     DOI： 10.1016/j.cellsig.2020.109694

Source DB:  PubMed          Journal:  Cell Signal        ISSN： 0898-6568            Impact factor:   4.315


  5 in total

1.  C1q/TNF-Related Protein 9 Attenuates Atherosclerosis by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the AMPKα/KLF4 Signaling Pathway.

Authors:  Gang Wang; Baihe Han; Ruoxi Zhang; Qi Liu; Xuedong Wang; Xingtao Huang; Dandan Liu; Weishen Qiao; Mengyue Yang; Xing Luo; Jingbo Hou; Bo Yu
Journal:  Front Pharmacol       Date:  2021-10-22       Impact factor: 5.810

2.  CTRP9 decreases high glucose‑induced trophoblast cell damage by reducing endoplasmic reticulum stress.

Authors:  Lianxiao Zhang; Huiqing Ding; Yubo Shi; Duoyi Zhang; Xue Yang
Journal:  Mol Med Rep       Date:  2022-03-29       Impact factor: 2.952

Review 3.  C1q/Tumor Necrosis Factor-Related Protein 9: Basics and Therapeutic Potentials.

Authors:  Hua Guan; Yanli Wang; Xiangyu Li; Aoqi Xiang; Fengwei Guo; Jianglin Fan; Qi Yu
Journal:  Front Physiol       Date:  2022-03-18       Impact factor: 4.566

Review 4.  Putative therapeutic impacts of cardiac CTRP9 in ischaemia/reperfusion injury.

Authors:  Seyyed-Reza Sadat-Ebrahimi; Hassan Amini; Reza Rahbarghazi; Paria Habibollahi; Shahrouz Ghaderi; Hadi Rajabi; Aysa Rezabakhsh
Journal:  J Cell Mol Med       Date:  2022-05-10       Impact factor: 5.295

5.  Expression of Serum Omentin, CTRP9, and Vaspin in Patients with Polycystic Ovary Syndrome.

Authors:  Yuhong Wang; Ning Liu; Jing Lu; Liping Yang; Changyan Wang; Jing Chen; Wenliang Chang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-17       Impact factor: 2.650
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.